Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Biochim Biophys Acta Mol Cell Res. 2020 Jun 26;1867(10):118786. doi: 10.1016/j.bbamcr.2020.118786

Table 1.

Total number of HTS hits compared with total number of compounds screened by kinase target.

Target # Screened Compounds # Hits Hit %
Src 31 20 0.65
JAK 47 28 0.60
PKC 21 12 0.57
VEGFR 64 34 0.53
GSK3 33 17 0.52
NF-kB 36 18 0.50
Raf 24 11 0.46
FLT3 11 5 0.45
STAT3 7 3 0.43
Akt 29 11 0.38
p38 MAPK 27 10 0.37
MEK 28 9 0.32
Raf 23 7 0.30
Wee1 7 2 0.29
Syk 18 5 0.28
PI3K 64 16 0.25
EGFR 75 13 0.17
mTOR 37 6 0.16